Prevention of rat liver fibrosis and carcinogenesis by coffee and caffeine
Introduction
The majority of human chronic liver diseases follow a common pathway that is initiated by inflammation leading to fibrosis and cirrhosis, which are associated with high indexes of morbidity and mortality worldwide (Wanless, 2004, Lim and Kim, 2008, Hernandez-Gea and Friedman, 2011). Liver fibrosis and cirrhosis are consequences of a continuous regenerative process in response to sustained noxious stimuli, such as chronic hepatitis B and C infections or chronic alcohol abuse (Wanless, 2004, Lim and Kim, 2008, Hernandez-Gea and Friedman, 2011). Cirrhosis is an irreversible and terminal step in the fibrotic process, characterised by impairment of hepatic architecture and function (Wanless, 2004, Lim and Kim, 2008, Fallowfield et al., 2006, Kisseleva and Brenner, 2007, Hernandez-Gea and Friedman, 2011).
The fibrotic/cirrhotic process leads to the formation of hepatic nodules and the accumulation of extracellular matrix proteins, mainly collagens I and III, proteoglycans and glycoproteins (Wanless, 2004, Kisseleva and Brenner, 2007, Hernandez-Gea and Friedman, 2011). This process starts with a cascade of events leading to recruitment of inflammatory cells and activation of collagen-producing cells, including hepatic stellate cells (Kisseleva and Brenner, 2007, Hernandez-Gea and Friedman, 2011). Because chronic fibrosis/cirrhosis can lead to the development of hepatocellular carcinoma, there have been increased efforts to develop preventive strategies to inhibit the progression of fibrosis/cirrhosis and consequently, tumour development (Fallowfield et al., 2006, Kisseleva and Brenner, 2007, Hoshida et al., 2012).
Coffee is one of the most popular and highly consumed beverages worldwide, and its moderate intake has been considered to be safe and beneficial for human health (Heckman et al., 2010, Butt and Sultan, 2011). Consumption of more than three cups of coffee per day has been inversely related to the incidence of non-alcoholic fatty liver disease, fibrosis/cirrhosis and hepatocellular carcinoma development in subjects with or without hepatitis B and/or C infection (Klatsky et al., 2006, Bravi et al., 2007, Catalano et al., 2010, Modi et al., 2010, Costentin et al., 2011, Leung et al., 2011). Mechanistic studies have suggested that coffee, caffeine and/or diterpenes cafestol and kahweol intake are beneficial due to antioxidant properties including increase in glutathione levels and modifying effects on phase I-activating and phase II-detoxifying enzymes, leading to protection against the development of liver diseases (Cadden et al., 2007, Lee et al., 2007, Huber et al., 2008, Cavin et al., 2008, Tao et al., 2008, Boettler et al., 2011). However, whether this protection is exerted by coffee per se or by specific components, such as caffeine, chlorogenic acid and the diterpenes cafestol and kahweol, remains controversial (Cadden et al., 2007, Huber et al., 2008, Cavin et al., 2008, Tao et al., 2008, Boettler et al., 2011). Experimental studies have suggested that the intake of instant coffee, conventional coffee, caffeine or the diterpenes cafestol and kahweol can reduce hepatotoxicant-induced liver fibrosis in male rats and mice (Ozercan et al., 2006, Lee et al., 2007, Shi et al., 2010, Shin et al., 2010, Moreno et al., 2011, Furtado et al., 2012).
A few in vivo studies attempted to elucidate the modifying effects of coffee or caffeine intake on the process of chemically-induced liver carcinogenesis (Hasegawa et al., 1995, Hosaka et al., 2001, Silva-Oliveira et al., 2010, Fujise et al., 2012). In addition, the available investigations are difficult to compare due to the different doses and types of coffee preparations adopted. Thus, the present study aimed to elucidate the beneficial effects of different coffee beverages (conventional and instant) and caffeine alone against chemically induced fibrosis and carcinogenesis in the liver of male Wistar rats.
Section snippets
Animals and housing environment
Male Wistar rats, 4-week-old, were purchased from the Multidisciplinary Centre for Biological Investigation (CEMIB/UNICAMP, Campinas-SP, Brazil) and housed at the animal facility of the Department of Pathology-Botucatu School of Medicine/UNESP Sao Paulo State University. The animals were housed in polypropylene cages (four animals/cage) covered with metallic grids in a room maintained at 22 ± 2 °C with 55 ± 10% humidity, a 12-h light–dark cycle and continuous air exhaustion. The animals were
General findings
The ingestion of coffee beverages and caffeine (G2–G4) did not alter body weight, food and liquid consumption, relative liver weight or serum levels of triglycerides and cholesterol as compared to the control group receiving drinking water (G1) (Table 1). Serum ALT levels were lower in the groups receiving coffee beverages or 0.1% caffeine (G2–G4), one week after the last CCl4 administration, than in the control group (G1) (Table 1). The concentrations of caffeine, chlorogenic acid and
Discussion
The present study evaluated the protective effects of coffee beverages and caffeine on liver fibrosis and carcinogenesis induced by the DEN/CCl4 regimen in male Wistar rats. The most pronounced beneficial effect against liver fibrosis was observed in the groups receiving conventional coffee and 0.1% caffeine, and the greatest effects against liver carcinogenesis were detected in the groups receiving instant coffee and 0.1% caffeine. Importantly, the caffeine doses used here (equivalent to
Conflict of Interest
The authors declare that they have no competing interests.
Authors’ contributions
Kelly Silva Furtado, Marcos Correa Dias and Luís F. Barbisan were in charge of the experimental protocol, analysis and interpretation of the results. They participated in the preparation of the manuscript. Maria A M Rodrigues was the group pathologist. She participated in the analysis, interpretation of the results and preparation of the manuscript. Jossimara Polettini was responsible for the molecular analysis and preparation of the manuscript.
Acknowledgements
This study was supported by FAPESP (08/50985-5) and CNPq (474572/2008-0). Furtado, KS, and Barbisan, LF, were recipients of fellowships from FAPESP (07/54858-5, 09/50890-7) and CNPq (301585/2009-1), respectively.
References (47)
- et al.
Induction of Nrf2-mediated cellular defences and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver
Food Chem. Toxicol.
(2008) - et al.
Collaborative SIDECIR Group: Coffee, caffeine, and the risk of liver cirrhosis
Annu. Epidemiol.
(2001) - et al.
Association of caffeine intake and histological features of chronic hepatitis C
J. Hepatol.
(2011) - et al.
Reversal of fibrosis: No longer a pipe dream?
Clin. Liver Dis.
(2006) In the search of the magic bullet
Gastroenterology
(2010)- et al.
Hallmarks of cancer: the next generation
Cell
(2011) - et al.
Analysis of the potential carcinogenicity of coffee and its related compounds in a medium-term liver bioassay of rats
Food Chem. Toxicol.
(1995) - et al.
Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene
Food Chem. Toxicol.
(2001) - et al.
Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver
Food Chem. Toxicol.
(2008) - et al.
Bcl-2-family proteins and the role of mitochondria in apoptosis
Curr. Opin. Cell Biol.
(2003)